程能能,陈斌艳,王永铭

• 1:复旦大学药学院药理教研室
• 2:复旦大学药学院药理教研室
• 3:复旦大学药学院药理教研室 上海200032
• 4:上海200032

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 程能能,陈斌艳,王永铭

DOI: 10.19577/j.cnki.issn10074406.2002.01.027

参考文献(References)：

• [1]MassarellaJW ,HeGZ ,DorrA ,etal.Thepharmacokineticsandtolerabilityoftheoralneuraminidaseinhibitoroseltamivirinhealthyadultandelderlyvolunteers[J].JClinPharmacol,2000,40:836.
• [2]CentersforDiseaseControlandPrevention.Preventionandcontrolofin fluenza:recommendationsoftheAdvisoryCommitteeonImmunizationPractices(ACIP)[C].MMWRMorbMortalWklyRep,2000,49(RR 03):1.
• [3]MusichSA ,BurtonWN ,EdingtonDW .Costsandbenefitsofpreventionanddiseasemanagement[J].DisManageHealthOutcomes,1999,5:153.
• [4]HeG ,MassarellaJ,WardP .ClinicalpharmacokineticsoftheprodrugoseltamiviranditsactivemetaboliteRo640802[J].ClinPharma cokinet,1999,37:471.
• [5]HayAJ .TheactionofadamantanaminesagainstinfluenzaAviruses:in hibitionoftheM2ionchannelprotein[J].SeminVirol,1992,3:21.
• [6]CentersforDiseaseControlandPrevention.Preventionandcontrolofin fluenza:recommendationsoftheAdvisoryCommitteeonImmunizationPractices(ACIP)[C].MMWRMorbMortalWklyRep,1998,47(RR 0):1.
• [7]GubarevaLV ,KaiserL ,HaydenFG .Influenzavirusneuraminidaseinhibitors[J].Lancet,2000,355:827.
• [8]McClellanK ,PerryCM .Oseltamivir:areviewofitsuseininfluenza[J].Drugs,2001,61(2):263.
• [9]KimCU ,LewW ,WilliamsMA ,etal.Influenzaneuraminidasein hibitorspossessinganovelhydrophobicinteractionintheenzymeactivesite:design,synthesis,andstructuralanalysisofcarbocyclicsialicacidanalogueswithpotentanti influenzaactivity[J].JAmChemSoc,1997,119:681.
• [10]VargheseJN ,ColmanPM .Three dimensionalstructureoftheneu raminidaseofinfluenzavirusA/Tokyo/3/67at22Aresolution[J].JMolBiol,1991,221:473.
• [11]ColmanPM ,HoynePA ,LawrenceMC .Sequenceandstructurealign mentofparamyxovirushemagglutinin neuraminidasewithinfluenzavirusneuraminidase[J].JVirol,1993,67:2972.
• [12]CalfeeDP ,HaydenFG .Newapproachestoinfluenzachemotherapy:neuraminidaseinhibitors[J].Drugs,1998,56:537.
• [13]MendelDB ,TaiCY ,EscarpePA ,etal.Oraladministrationofapro drugoftheinfluenzavirusneuraminidaseinhibitorGS4071protectsmiceandferretsagainstinfluenzainfection[J].AntimicrobAgentsChemo ther,1998,42:640.
• [14]SidwellRW ,BaileyKW ,BemisPA ,etal.Influenceoftreatmentscheduleandviralchallengedoseontheinvivoinfluenzavirus inhibito ryeffectsoftheorallyadministeredneuraminidaseinhibitorGS 4104[J].AntivirChemChemother,1999,10:187.
• [15]HaydenFG ,TreanorJJ,FritzRS ,etal.Useoftheoralneuraminidaseinhibitoroseltamivirinexperimentalhumaninfluenza,randomizedcon trolledtrialsforpreventionandtreatment[J].JAMA ,1999,282:1240.
• [16]HaydenFG ,JenningsL ,RobsonR ,etal.OraloseltamivirinhumanexperimentalinfluenzaBinfection[J].AntiviralTherapy,2000,5(3):205.
• [17]HaydenFG ,AtmarRL ,SchillingM ,etal.Useoftheselectiveoralneuraminidaseinhibitoroseltamivirtopreventinfluenza[J].NEnglJMed,1999,341:1336.
• [18]WelliverR ,MontoAS ,CareviczO ,etal.Effectivenessofoseltamivirinpreventinginfluenzainhouseholdcontacts.Arandomizedcontrolledtrial[J].JAMA ,2001,285(6):748.
• [19]TreanorJJ,HaydenFG ,VroomanPS ,etal.Efficacyandsafetyoftheoralneuraminidaseinhibitoroseltamivirintreatingacuteinfluenza,arandomizedcontrolledtrial[J].JAMA ,2000,283:1016.
• [20]NicholsonKG ,AokiFY ,OsterhausA ,etal.Efficacyandsafetyofoseltamivirintreatmentofacuteinfluenza:arandomizedcontrolledtrial[J].Lancet,2000,355:1845.
• [21]WhitleyRJ,HaydenFG ,ReisingerKS ,etal.Oraloseltamivirtreat mentofinfluenzainchildren[J].PediatrInfectDisJ,2001,20:127.
• [22]MendelDB ,TaiCY ,EscarpePA .Invitroselectionandcharacteriza tionofahumaninfluenzaviruswithdecreasedsusceptibilitytoGS 4071[J].AntiviralRes,1998,37:A71.
• [23]TaiCY ,EscarpePA ,SidwellRS ,etal.Characterizationofhumanin fluenzavirusvariantsselectedinvitrointhepresenceoftheneu raminidaseinhibitorGS 4071[J].AntimicrobAgentsChemother,1998,42(12):3234.
• [24]HeG ,MassarellaJ,WardP .ClinicalpharmacokineticsoftheprodrugoseltamiviranditsactivemetaboliteRo640802[J].ClinPharma cokinet,1999,37:471.
• [25]MassarellaJW ,HeGZ ,DorrA ,etal.Thepharmacokineticsandtolerabilityoftheoralneuraminidaseinhibitoroseltamivir(Ro640796/GS4104)inhealthyadultandelderlyvolunteers[J].JClinPharmacol,2000,40(8):836.
• [26]OoC ,BarrettJ,MannJ,etal.Pharmacokineticsoftheoralneu raminidaseinhibitoroseltamivirinpediatricpatients[J].ClinMicrobiolInfect,2000,6(Supp11):202.
• [27]HeG ,MassarellaJ,AitkenM ,etal.ThepharmacokineticsandsafetyoftheoralneuraminidaseinhibitorRO 640796/GS4104whenadminis teredconcurrentlywithcimetidineorprobenecidinhealthysubjects[J].JAntimicrobChemother,1999,44(Supp1A):44.
• [28]McNichollIR ,McNichollJJ.Neuraminidaseinhibitors:zanamivirandoseltamivir[J].AnnPharmacother,2001,35:57.